DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Access to Medicine Index
Access to Medicine Index
Access to Medicine Index Scoping Report & Stakeholder Review
2020 Health for Humanity Report
The Access to Medicine Index 2014 Access to Medicine Foundation Scheepmakersdijk 5A NL-2011 AS Haarlem the Netherlands
Access to Medicine Index 2018 Methodologyaccess to REPORT Medicine Index 2018 Methodology Report 2017
Access to Medicine Index 2018 Access to Medicine Foundation
P a T I E N T S Innovation P a R T N E
The Role of Intellectual Property in Local Production in Developing
New Products Alone Are Not Enough. Pharma Can Do More to Halt COVID-19
Taming Big Pharma Assessing How Insurers Push Pharmaceutical Companies to Improve Access to Medicine and Pay Fair Taxes
Patients at Our Center Pfizer 2018 Annual Review from Leadership Our Business Our Innovation Our Culture, Our Purpose Our Performance
The Access to Medicine Index 2014 Access to Medicine Foundation Scheepmakersdijk 5A NL-2011 AS Haarlem the Netherlands
Ten-Year Impact of the Access to Medicine Index: Changes in Industry Pricing and Intellectual Property Policies in Low- and Middle-Income Countries from 2008-2018
Second-Party Opinion Novartis Sustainability-Linked Notes
219 the Study of the Major International Rating
Access to Medicine Index 2021 METHODOLOGY
Annual Report 2014
Q1 2021 Presentation
2020 Environmental, Social and Governance Report
Top View
Find out How Investment Management
Are Pharmaceutical Companies Making Progress When It Comes to Global Health?
Access to Medicine Index 2021 METHODOLOGY
Access to Medicine Index 2016 ACCESS to MEDICINE FOUNDATION the Access to Medicine Foundation Is a Non-Profit Organisation
Access to Medicine Index
The Access to Medicine Index 2012 Access to Medicine Index 2012